Clovis Oncology CLVS reported its Q2 earnings results on Monday, August 8, 2022 at 06:00 AM.
Here's what investors need to know about the announcement.
Earnings
Clovis Oncology missed estimated earnings by 21.95%, reporting an EPS of $-0.5 versus an estimate of $-0.41.
Revenue was down $4.68 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.01 which was followed by a 12.5% drop in the share price the next day.
Here's a look at Clovis Oncology's past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.43 | -0.56 | -0.48 | -0.56 |
| EPS Actual | -0.44 | -0.48 | -0.56 | -0.59 |
| Revenue Estimate | 36.97M | 39.08M | 39.09M | 41.12M |
| Revenue Actual | 34.25M | 35.97M | 37.92M | 36.82M |
To track all earnings releases for Clovis Oncology visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
